Latest News
Francesco De Rubertis, co-founder and partner at Medicxi (left) and Graziano Seghezzi, managing partner at Sofinnova Partners (right).
Investment
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Sofinnova and Medicxi talk M&A, patent cliffs, and China
While we are only in the first two months of the year, Sofinnova and Medicxi spoke to us candidly about investment trends, landscapes, and how investment activity remains integral to the biotech space.
Introducing the Investival Showcase, North America's newest platform where innovation meets opportunity, featuring exclusive 1:1 partnering sessions at its core. After a decade of success in Europe, seamlessly connecting visionary life science and healthcare leaders with investors and strategic partners, we're bringing this powerhouse event stateside.
REGISTERNews from APAC
See allEurope's Largest Springtime Biotech Partnering Event
REGISTERBIO-EUROPE COVERAGE
BIO-EUROPE COVERAGEC-Suite Conversations
See allpartneringONE’s first-in-class partnering technology powers global events and enhances your networking experience.
‘Houston, we have a talent problem!’ TMC taps up next gen of biopharma experts
Non-profit organization Learning Undefeated has partnered with the Texas Medical Center (TMC) to help underrepresented students build biomanufacturing careers.
Partnerships underpin the CRISPR revolution, says Caszyme CEO
Integra Therapeutics will use Caszyme’s genome editor Cas12l in its FiCAT 2.0 gene-writing platform to develop safer and more effective cell and gene therapies.
Eyes on Asia: BIOSECURE, Merck & Hansoh, Roche adds ADC, and Samsung
BioXconomy presents the Asia biopharma and healthcare dealmaking and financing news for the week ending 5 January.
Partnering Deals
See allSubscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.